Back
MicroStrategy Vs. Spyre Therapeutics Industry Stock Comparison
Buy
64
MSTR
MicroStrategy
Last Price:
176.02
Seasonality Move:
28.67%
Buy
59
SYRE
Spyre Therapeutics
Last Price:
28.46
Seasonality Move:
-2.85%
Buy
64
MicroStrategy (MSTR)
is a Buy
Is MicroStrategy a Buy, Sell or Hold?
- The current MicroStrategy [MSTR] share price is $165.98. The Score for MSTR is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
- MSTR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
59
Spyre Therapeutics (SYRE)
is a Buy
Is Spyre Therapeutics a Buy, Sell or Hold?
- The current Spyre Therapeutics [SYRE] share price is $29.04. The Score for SYRE is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
- SYRE is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
MSTR Stock Price Chart
What is MicroStrategy's stock price today?
-
The MicroStrategy share price today is $165.98
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MSTR is experiencing buying pressure, which is a positive indicator for future bullish movement.
SYRE Stock Price Chart
What is Spyre Therapeutics's stock price today?
-
The Spyre Therapeutics share price today is $29.04
The current trend is moderately bearish and SYRE is experiencing slight buying pressure.
MSTR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.89 | Buy |
| Relative Strength Index (14 RSI): | 67.38 | Buy |
| Chaikin Money Flow: | 12243782 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (124.67 - 148.51) | Buy |
| Bollinger Bands (100): | (129.37 - 160.73) | Buy |
SYRE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.41 | Buy |
| Relative Strength Index (14 RSI): | 53.02 | Buy |
| Chaikin Money Flow: | 71063 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (26.98 - 29.52) | Buy |
| Bollinger Bands (100): | (25.44 - 33.84) | Sell |
MSTR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 146.93 | Buy |
| 20-day SMA: | 135.6 | Buy |
| 50-day SMA: | 142.53 | Buy |
| 200-day SMA: | 121.39 | Buy |
| 8-day EMA: | 149.63 | Buy |
| 20-day EMA: | 141.74 | Buy |
| 50-day EMA: | 140.56 | Buy |
| 200-day EMA: | 120.96 | Buy |
SYRE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 29.1 | Sell |
| 20-day SMA: | 28.66 | Buy |
| 50-day SMA: | 27.88 | Buy |
| 200-day SMA: | 29.31 | Sell |
| 8-day EMA: | 28.88 | Buy |
| 20-day EMA: | 28.56 | Buy |
| 50-day EMA: | 28.37 | Buy |
| 200-day EMA: | 27.36 | Buy |
MicroStrategy Earnings Growth & MSTR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.09 per share, an increase next quarter of $0.08 per share, a decrease this year of $4.19 per share, and an increase next year of $1.59 per share.
Spyre Therapeutics Earnings Growth & SYRE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.05 per share, an increase next quarter of $0.24 per share, an increase this year of $9.51 per share, and an increase next year of $0.02 per share.
MicroStrategy Technical Analysis
| Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Spyre Therapeutics Technical Analysis
| Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||